No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 1,100,039 | 1,071,453 | 1,149,370 | 1,359,115 | 1,439,231 | 1,530,556 | 1,583,719 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 18,837 | 59,416 | 75,725 | 94,065 | 87,121 | 70,272 | 134,675 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Ajinomoto Co., Inc. is a Japanese multinational corporation with a global presence, specializing in three main business areas: seasonings and food products, frozen culinary items, and a diverse healthcare and specialty chemicals portfolio. Its Seasonings and Foods division offers an extensive range of sauces and seasonings, featuring well-known brands such as AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY. This segment also provides tailored ingredient solutions for both consumer packaged goods and the food service industry. Beyond culinary staples, it includes popular instant noodle brands like Knorr Cup Soup and YumYum, various coffee products under the Birdy and Blendy labels, the Birdy 3in1 powdered drink, MAXIM products, and Chyotto Zeitakuna Kohiten items. Additionally, it supplies gift sets and office amenities, including coffee vending machines and tea servers. Within the Frozen Foods segment, the company produces a variety of convenient meal options such as Chinese dumplings, cooked rice dishes, noodles, desserts, shumai, and processed chicken products. The Healthcare and Other segment demonstrates significant diversification. It supplies amino acids for a range of applications in the pharmaceutical, food, and cosmetic industries, alongside sports nutrition products and personal care ingredients. This division also provides sterile products and specialized contract manufacturing services for pharmaceutical intermediates and active ingredients. A notable offering is the Ajinomoto Build-up Film, an advanced interlayer insulating material crucial for semiconductor packages. Ajinomoto Co., Inc. was established in 1909 and maintains its headquarters in Tokyo, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Ajinomoto Co., Inc. (2802.T)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Ajinomoto Co., Inc. is a Japanese multinational corporation with a global presence, specializing in three main business areas: seasonings and food products, frozen culinary items, and a diverse healthcare and specialty chemicals portfolio. Its Seasonings and Foods division offers an extensive range of sauces and seasonings, featuring well-known brands such as AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY. This segment also provides tailored ingredient solutions for both consumer packaged goods and the food service industry. Beyond culinary staples, it includes popular instant noodle brands like Knorr Cup Soup and YumYum, various coffee products under the Birdy and Blendy labels, the Birdy 3in1 powdered drink, MAXIM products, and Chyotto Zeitakuna Kohiten items. Additionally, it supplies gift sets and office amenities, including coffee vending machines and tea servers. Within the Frozen Foods segment, the company produces a variety of convenient meal options such as Chinese dumplings, cooked rice dishes, noodles, desserts, shumai, and processed chicken products. The Healthcare and Other segment demonstrates significant diversification. It supplies amino acids for a range of applications in the pharmaceutical, food, and cosmetic industries, alongside sports nutrition products and personal care ingredients. This division also provides sterile products and specialized contract manufacturing services for pharmaceutical intermediates and active ingredients. A notable offering is the Ajinomoto Build-up Film, an advanced interlayer insulating material crucial for semiconductor packages. Ajinomoto Co., Inc. was established in 1909 and maintains its headquarters in Tokyo, Japan.
